CP and infection: The transgenic lines presented a 25% reduction in the disease index (37.78% vs. WT 50.37%; p < 0.01, Table 3) and 3.2-fold lower viral cp expression (Figure 5b), indicating that their resistance to ChiVMV was significantly increased and that CaPR1 had a positive regulatory effect on ChiVMV infection.